Loading
A phase 2 trial of fruquintinib in colorectal cancer, run by Meng Qiu, not yet recruiting.
SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study is a phase 2, interventional study registered as NCT07515820 by Meng Qiu, with a registry enrolment figure of 12 participants, started 2026-04-27 and due to reach its primary completion in 2027-07-28. Interventions recorded: SHR-3821 and fruquintinib. Conditions listed: Colorectal Cancer. Primary outcome: Incidence of treatment related adverse event [Safety and Tolerability]; Objective response rate (ORR). Colorectal eligibility wording from the registry: "Histologically or cytologically confirmed unresectable recurrent or metastatic colorectal cancer". No results are recorded here; the registry entry is the source.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.